Abstract
Purpose
To determine the risk factors that induce an elevation of intraocular pressure (IOP) after trans-Tenon retrobulbar injections of triamcinolone acetonide.
Methods
We retrospectively reviewed the medical records of 49 consecutive patients (49 eyes) with choroidal neovascularization or diffuse diabetic macular edema who had received one trans-Tenon retrobulbar injection of triamcinolone acetonide (20 mg) between June 2003 and September 2004, while being treated at Kagawa University Hospital or Okayama Saiseikai General Hospital. Diabetes mellitus had been diagnosed in ten of the patients. Steroid responders were defined as having a relative increase in intraocular pressure (IOP) of >6 mmHg and an absolute IOP >20 mmHg with an anatomically open anterior chamber angle. The mean follow-up time was 4.2 ± 0.2 months (range, 3–6 months).
Results
Nine patients were responders and 40 patients were nonresponders. The elevation of the IOP occurred 1 to 4 weeks after the injection. The only preoperative predictive factor for the steroid responders was the presence of diabetes mellitus (multiple logistic regression analysis, odds ratio = 32.78, P = 0.006). After topical glaucoma medication, the IOP returned to acceptable levels in all responders.
Conclusions
Our results suggest an association between diabetes mellitus and elevated IOP after a trans-Tenon retrobulbar triamcinolone acetonide injection. Jpn J Ophthalmol 2006;50:235–238 © Japanese Ophthalmological Society 2006
Similar content being viewed by others
References
MF Armaly (1965) ArticleTitleStatistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response Invest Ophthalmol 26 187–197
B Becker (1965) ArticleTitleIntraocular pressure response to topical corticosteroids Invest Ophthalmol 26 198–205
AF Clark (1995) ArticleTitleSteroids, ocular hypertension, and glaucoma J Glaucoma 4 354–369
RS Coles DL Krohn H Breslin R Braunstein (1962) ArticleTitleDepo-Medrol in treatment of inflammatory diseases Am J Ophthalmol 54 407–411 Occurrence Handle13880494 Occurrence Handle1:STN:280:CC2D387nvFc%3D
TF Schlaegel SuffixJr JC Weber (1997) ArticleTitleTreatment of pars planitis, II: corticosteroids Surv Ophthalmol 22 125–130
V Tanner JJ Kanski PA Frith (1998) ArticleTitlePosterior sub-Tenon's triamcinolone injections in the treatment of uveitis Eye 12 679–685 Occurrence Handle9850264
GJ Jaffe J Ben-Nun H Guo JP Dunn P Ashton (2000) ArticleTitleFluocinolone acetonide sustained drug delivery device to treat severe uveitis Ophthalmology 107 2024–2033 Occurrence Handle11054326 Occurrence Handle1:STN:280:DC%2BD3M%2FivFygsw%3D%3D Occurrence Handle10.1016/S0161-6420(00)00466-8
JB Jonas A Sofker (2001) ArticleTitleIntraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema Am J Ophthalmol 132 425–427 Occurrence Handle11530068 Occurrence Handle1:STN:280:DC%2BD3MvoslOrsg%3D%3D Occurrence Handle10.1016/S0002-9394(01)01010-8
PB Greenberg A Martidis AH Rogers JS Duker E Reichel (2002) ArticleTitleIntravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion Br J Ophthalmol 86 247–248 Occurrence Handle11815359 Occurrence Handle10.1136/bjo.86.2.247
N Ohguro AA Okada Y Tano (2004) ArticleTitleTrans-Tenon's retrobulbar triamcinolone infusion for diffuse diabetic macular edema Graefes Arch Clin Exp Ophthalmol 242 444–445 Occurrence Handle14747952 Occurrence Handle10.1007/s00417-003-0853-z
AA Okada T Wakabayashi E Kojima Y Asano T Hida (2004) ArticleTitleTrans-Tenon's retrobulbar triamcinolone infusion for small choroidal neovascularization Br J Ophthalmol 88 1097–1098 Occurrence Handle15258036 Occurrence Handle1:STN:280:DC%2BD2czlsVygtg%3D%3D Occurrence Handle10.1136/bjo.2003.039719
T Wakabayashi AA Okada Y Morimura et al. (2004) ArticleTitleTrans-Tenon retrobulbar triamcinolone infusion for chronic macular edema in central and branch retinal vein occlusion Retina 24 964–967 Occurrence Handle15579998 Occurrence Handle10.1097/00006982-200412000-00020
CM Morgan H Schatz AK Vine et al. (1988) ArticleTitleOcular complications associated with retrobulbar injections Ophthalmology 95 660–665 Occurrence Handle3174025 Occurrence Handle1:STN:280:BiaD3MrntFY%3D
DS Levin DP Han S Dev et al. (2002) ArticleTitleSubtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation Am J Ophthalmol 133 196–202 Occurrence Handle11812422 Occurrence Handle1:CAS:528:DC%2BD38XmsFyqug%3D%3D Occurrence Handle10.1016/S0002-9394(01)01372-1
LM Jampol (1985) ArticleTitlePharmacologic therapy of aphakic and pseudophakic cystoid macular edema Ophthalmology 92 807–810 Occurrence Handle3897936 Occurrence Handle1:STN:280:BiqB1MjitVM%3D
CJ Helm GN Holland (1995) ArticleTitleThe effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis Am J Ophthalmol 120 55–64 Occurrence Handle7611330 Occurrence Handle1:STN:280:ByqA3srntFM%3D
AJ Mueller G Jian AS Banker FM Rahhal E Capparelli WR Freeman (1998) ArticleTitleThe effect of deep posterior subtenon injection of corticosteroids on intraocular pressure Am J Ophthalmol 125 158–163 Occurrence Handle9467440 Occurrence Handle1:CAS:528:DyaK1MXkvV2ksbY%3D Occurrence Handle10.1016/S0002-9394(99)80085-3
RE Kalina (1969) ArticleTitleIncreased intraocular pressure following subconjunctival corticosteroid administration Arch Ophthalmol 81 788–790 Occurrence Handle5783749 Occurrence Handle1:STN:280:CCaB3c3ot1I%3D
J Herschler (1976) ArticleTitleIncreased intraocular pressure induced by repository corticosteroids Am J Ophthalmol 82 90–93 Occurrence Handle937460 Occurrence Handle1:STN:280:CSmB38bgvFA%3D
ML Smithen DM Ober L Maranan FR Spaide (2004) ArticleTitleIntravitreal triamcinolone acetonide and intraocular pressure Am J Ophthalmol 138 740–743 Occurrence Handle15531307 Occurrence Handle1:CAS:528:DC%2BD2cXpsVOkurc%3D Occurrence Handle10.1016/j.ajo.2004.05.073
B Becker G Bresnick L Chevrette AE Kolker MC Oaks A Cibis (1966) ArticleTitleIntraocular pressure and its response to topical corticosteroids in diabetes Arch Ophthalmol 76 477–483 Occurrence Handle5928134 Occurrence Handle1:STN:280:CCiD2MzgslY%3D
J Hetherington RN Shaffer (1964) ArticleTitleGlaucoma Research Conference Am J Ophthalmol 58 1065
M Ohji S Kinoshita E Ohmi Y Kuwayama (1991) ArticleTitleMarked intraocular pressure response to instillation of corticosteroids in children Am J Ophthalmol 112 450–454 Occurrence Handle1928249 Occurrence Handle1:STN:280:By2D38nislI%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hirooka, K., Shiraga, F., Tanaka, S. et al. Risk Factors for Elevated Intraocular Pressure After Trans-Tenon Retrobulbar Injections of Triamcinolone. Jpn J Ophthalmol 50, 235–238 (2006). https://doi.org/10.1007/s10384-005-0306-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10384-005-0306-9